TOP STORIESmore
ANALYSISmore
Fed Will Not Hike Rates For Years. Gold Should Like It.
Sep 17,2020,17:29
Crude Oil - A Slight Move Higher Has Not Reversed The Bearish Trend
Sep 16,2020,15:16
Technically Speaking: Is Everything “Priced In?”
Sep 15,2020,19:56
THIRD-PARTY REPORTS
more
All reports in this column are submitted from third-party institutions, and we do not assume any legal responsibility for the content of the manuscript
I want to submit a report
COMMENTARYmore
IN THE NEWSmore
Hailiang Education Expands Its Network of Schools
Hailiang; China; U.S.
43 m ago
Happiness Biotech Steps Into E-commerce With Hive-Box
Happiness; HAPP; China; U.S.
Sep 17,2020,20:28
Baozun Launches Secondary Public Offering in Hong Kong
baozun, bzun, sehk
Sep 17,2020,17:33
The Benefits of Trading Forex Online
Trading Forex
Sep 15,2020,00:01
Huazhu Group Partners With Sino-Ocean Group
Huazhu; Sino-Ocean; China; U.S.
Sep 11,2020,18:52
China Online Education Drops Despite Revenue Growth
K-12; ChinaOnlineEducation; China; U.S.
Sep 08,2020,17:22
Biyao’s C2M Model at the Frontline of Tech-Driven Retail
C2M, E-commerce
Sep 07,2020,04:28
111 Expands in Digital Medicine Innovation
111; China; U.S.
Sep 04,2020,21:05
Zhongliang Sees Improvement in China's Real Estate Market
Zhongliang; China; HongKong
Sep 03,2020,21:44
China's First Insect Cell Covid-19 Vaccine Candidate Injected in Humans
Sinovac, Cansino, China,
Sep 01,2020,14:56
Research Report on Chinese companies
2020.09.18
more
CREDIT RATING OF CHINESE COMPANIES
MARKET INDICES
CEO INTERVIEWS / EVENTSmore
Do you really know Xiaolong Zhang?
The Making of a Power CEO
PRESS RELEASES
HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A++ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “aa+” of Samsung Fire & Marine Insurance Co., Ltd. (SFM) (South Korea). Concurrently, AM Best has affirmed the FSRs of A- (Excellent) and the Long-Term ICRs of “a-” of SFM’s subsidiaries, Samsung Vina Insurance Co., Ltd. (SVI) (Vietnam) and PT Asuransi Samsung Tugu (AST) (Indonesia). The outlook of these Credit Ratings (ratings) is
AM Best Affirms Credit Ratings of Samsung Fire & Marine Insurance Co., Ltd. and Its Subsidiaries; Revises Outlooks to Stable for Samsung Reinsurance Pte. Ltd.
06:56 AM
SHANGHAI, China--(BUSINESS WIRE)--The press conference of the 2nd Shanghai International Artwork Trade Month was held on the morning of September 15 (Tuesday), 2020 at West Bund, Shanghai. As was announced in the conference, the 2nd Shanghai International Artwork Trade Month will be held from October 15 to November 15 this year, and the Smart Artwork Display and Trading Platform will be launched on the same day of the conference, which simultaneously enables online registration through the plat
GLOBAL ART IN SHANGHAI TIME - The 2nd Shanghai International Artwork Trade Month Opening in October
05:35 AM
SHENZHEN, China--(BUSINESS WIRE)--Infinix, a global leader in consumer electronics, has launched its 2020 flagship smartphone, the Vision Master Zero 8. Beautifully designed, and built to capture stunning photos and videos, the Zero 8 is the result of relentless innovation, setting a benchmark as Infinix enters the high-end smartphone market in style. A versatile and powerful camera for stunning pictures every time Capture the beauty of every moment with the Infinix Zero 8’s advanced camera. No
Infinix Announces Zero 8: Flagship Excellence Across the Board
Sep 18,2020,00:07
HANGZHOU, China--(BUSINESS WIRE)--Alibaba Group will host a virtual 2020 Investor Day on September 28-30, 2020 China Standard Time.
Alibaba Group to Host Investor Day
Sep 17,2020,20:34
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BGNE--BeiGene presents Phase 3 data of tislelizumab in non-squamous non-small cell lung cancer and Phase 2 data of pamiparib in ovarian cancer at ESMO 2020.
BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer
Sep 17,2020,14:05
BEIJING & DURHAM, N.C.--(BUSINESS WIRE)--Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, announced today the appointments of Rogers Yongqing Luo, B.M., MBA, as President of the company and General Manager for greater China, and Ankang Li, Ph.D., J.D., CFA, as Chief Financial Officer of the company. Both executives are based in Shanghai. Dr. Luo will play a central role in ru
Brii Biosciences Appoints Rogers Luo, Ankang Li To Leadership Positions
Sep 17,2020,08:28
PARTNERSmore